Register 3 for the price of 2 with the coupon code rcdvb!

Overview | Speakers | Agenda | Poster Submissions | Venue | Sponsors

Dear Colleague,

With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets and therapeutics provide new opportunities for the prevention and treatment of several major disease systems. The 5th Cancer Targets & Therapeutics Conference, taking place on July 7-8, 2014 in Boston, MA will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.

2014 Session Topics:

I. Emerging Cancer Targets & Therapeutic Strategies
- Kinase Inhibitors
- Epigenetic Regulators
- Metabolic Pathways
- Cancer Stem Cells
II. Progress in Cancer Immunotherapy
III. Combination Strategies in Immuno-Oncology

This conference is part of our larger Novel Cancer Therapeutics Summit 2014, which includes one additional parallel conference:

Novel Cancer Therapeutics Summit 2014:
5th Cancer Targets & Therapeutics
3rd Oncology Partnering & Deal-Making

Sign up
for the Summit Pass to have access to both conferences of the summit!

Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405x110 or
amber.kempf [at] for more info.

Best Regards,

Organizing Committee

Attend ALL GTCbio Conferences for One Year for only $3,995 ($1,990 for Acad/Govt).
Click here to sign up!

5th Cancer Targets and Therapeutics Conference Overview